During the past decade, Ospedale degli Infermi - ASL 12 conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale degli Infermi - ASL 12" #1 sponsor was "ETOP IBCSG Partners Foundation" with 3 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 3 trials sponsored, "International Extranodal Lymphoma Study Group (IELSG)" with 2 trials sponsored, "Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy" with 1 trials sponsored and "Gruppo Oncologico del Nord-Ovest" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale degli Infermi - ASL 12" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale degli Infermi - ASL 12" are "Breast Cancer" (5 trials), "Marginal Zone Lymphoma" (2 trials), "Bladder Cancer" (1 trials), "CD20 Positive Diffuse Large B-cell Lymphoma" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Ospedale degli Infermi - ASL 12" in a lesser frequency.

Most popular intervention types in "Ospedale degli Infermi - ASL 12" are "Drug" (11 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (2 trials), "cyclophosphamide" (2 trials), "Bortezomib-Rituximab-Bendamustine" (1 trials), "Cyclophosphamide" (1 trials) and "Ga101" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale degli Infermi - ASL 12" are 8 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale degli Infermi - ASL 12". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ospedale degli Infermi - ASL 12, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale degli Infermi - ASL 12, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Ospedale degli Infermi - ASL 12 has several departments that took part in Clinical trials: "Ospedale Degli Infermi Di Biella; Reparto Oncologia Medica" - 5 trials